LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Manufacturing Facility
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • IR Inquiries
  • Stock Info
  • Disclosure
  • Financial Information
  • IR Inquiries

Disclosure

2022-08-06 05:04:59
No.DateDisclosure ContentsCompany
102022.08.05Interim Report on Business Performance(Fair Disclosure)MEDIPOSTCO.,LTD.
92022.07.29Outcomes of Extraordinary General Meeting of ShareholdersMEDIPOSTCO.,LTD.
82022.07.13[Revised]Resolutions for Convocation of General Meeting of ShareholdersMEDIPOSTCO.,LTD.
72022.07.04Material Management Information related to Judgment of Investment(무릎골관절염치료제 카티스템 말레이시아 품목허가(BLA) 자진철회)MEDIPOSTCO.,LTD.
62022.07.01[Revised]Decision on Acquisition of Shares or Investment Certificates of Other Corporation(Material Management Matters of Subsidiary Company)MEDIPOSTCO.,LTD.
52022.06.24[Revised]Decision on Acquisition of Shares or Investment Securities of Other CorporationMEDIPOSTCO.,LTD.
42022.06.24[Revised]Decision on Paid-in Capital Increase(Material Management Matters of Subsidiary Company)MEDIPOSTCO.,LTD.
32022.06.24Change of The Largest ShareholderMEDIPOSTCO.,LTD.
22022.06.24Results of issuance(Voluntary Disclosure)MEDIPOSTCO.,LTD.
12022.06.22Decision on Acquisition of Shares or Investment Securities of Other CorporationMEDIPOSTCO.,LTD.
  • Stock Info
  • Disclosure
  • Financial Information
  • IR Inquiries

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677
CUSTOMER CENTER
ONLINE INQUIRY

Latest News

·
MEDIPOST’s treatment for knee osteoarthritis, enters phase 3 clinical trials in Japan2022.03.25
·
MEDIPOST enters into new business and accelerates its clinical trials in the U.S. through third-party allotment financing2022.03.17
·
MEDIPOST’s injectable drug for knee osteoarthritis, SMUP-IA-01, enters phase 2 clinical trials in Korea2021.12.24
·
MEDIPOST receives approval to proceed with phase 2 clinical trial in Korea for its next-generation injectable drug for knee osteoarthritis, SMUP-IA-012021.10.27
·
MEDIPOST requests approval for the phase 2 clinical trial in Korea of its next-generation injectable drug for knee osteoarthritis, SMUP-IA-012021.07.30

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements
· LOCATION
· PRIVACY POLICY
©Copyright – The Future of Biotechnology, MEDIPOST